Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA Teniposide CTRPv2 pan-cancer AAC -0.033 0.4
mRNA CP466722 GDSC1000 pan-cancer AAC -0.024 0.4
mRNA embelin GDSC1000 pan-cancer AAC -0.029 0.4
mRNA JQ12 GDSC1000 pan-cancer AAC -0.028 0.4
mRNA necrostatin-1 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA AM-580 CTRPv2 pan-cancer AAC 0.03 0.4
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC 0.056 0.4
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.027 0.4
mRNA CH5424802 GDSC1000 pan-cancer AAC -0.027 0.4
mRNA GDC-0941 GDSC1000 pan-cancer AAC 0.026 0.4
Download CSV